Introduction
The intersection of Intellectual Property (IP) and Competition Law in India has reached a critical juncture. The core dispute centers on whether the Competition Commission of India (CCI) has the legal standing to investigate patent holders for anti-competitive behavior, or if such matters fall exclusively under the Patents Act, 1970. While recent rulings from the Delhi High Court and the National Company Law Appellate Tribunal (NCLAT) attempted to oust the CCI’s jurisdiction, a precedent setting intervention by the Supreme Court in CCI v. Swapan Dey1, has stayed those findings. This sets the stage for a definitive ruling on a jurisdictional clash that will determine whether patent exclusivity can be shielded from antitrust scrutiny.
The Judicial Seesaw: From Ericsson to Swapan Dey
The current legal uncertainty stems from the 2023 Delhi High Court judgment in Telefonaktiebolaget LM Ericsson (PUBL) v. CCI2. Applying the maxims Generalia specialibus non derogant (special law prevails over general law) and Lex posterior derogat priori (later law prevails over earlier law), the Court reasoned that the Patents Act extensively amended in 2003 should take precedence over the Competition Act of 2002. It concluded that the Patents Act is a “complete code” for addressing licensing abuses. This line of reasoning was adopted by the NCLAT in 2025 in the Swapan Dey case, involving a patented iron-deficiency drug. However, by staying the NCLAT’s order in early 2026, the Supreme Court has signaled that the CCI’s role as a market regulator may not be so easily dismissed.
The primary argument for ousting the CCI’s authority is the existence of Compulsory Licensing (CL) under Section 84 of the Patents Act3. Yet, history suggests CL was never meant to be an exhaustive remedy for market distortions. The Ayyangar Committee Report4, which shaped the current patent regime, noted that the “abuse of monopoly” was a concept too narrow for patent law alone to solve. Justice Ayyangar observed that patents could become “nuclei” for restrictive practices that require oversight beyond the technical scope of a Patent Controller. This historical context indicates that the Patents Act was designed for individual economic adjustment, while an overarching authority like the CCI is necessary to handle systemic market harms.
Interlinking Patent Misuse and Competition Standards
The Patents Act contains its own restrictive-condition standard under Section 1405, which voids contract terms that unfairly limit a licensee. However, there is a fundamental functional difference between this and the Competition Act. While the Patent Controller examines the relationship between specific parties to ensure an invention is “worked” in the public interest, the CCI operates in-rem. The CCI’s mandate is to protect the entire market from an Appreciable Adverse Effect on Competition (AAEC). By removing the CCI from the equation, regulators risk a “gap” where a patentee satisfies the technical supply requirements of the Patents Act while simultaneously using exclusionary tactics to stifle competitors across the broader industry.
A worrying trend has emerged where private settlements are used to terminate CCI investigations. In JCB v. CCI (2024)6. The Delhi High Court suggested that once parties settle, the basis for a competition dispute vanishes. This contradicts the Supreme Court’s stance in Samir Agrawal v. CCI7, which clarified that CCI proceedings are inquisitorial and serve the public interest. Unlike a private civil suit, an informant merely triggers an investigation that is intended to benefit the entire market. Allowing private deals to end these probes encourages “tactical litigation,” where companies use the threat of a CCI investigation to extract better licensing terms, then withdraw, leaving anti-competitive market structures untouched.
Conclusion
While recent lower court rulings favored patent holders by prioritizing the Patents Act as a special law, the Supreme Court’s 2026 intervention suggests that intellectual property rights cannot be used as a shield against antitrust scrutiny. While the Patent Controller manages individual licensing disputes (in personam), only the CCI possesses the mandate to prevent systemic market distortions (in rem). Allowing private settlements to kill CCI investigations risks “tactical litigation,” where public market interests are sacrificed for private corporate gain. Ultimately, maintaining an equilibrium where the CCI acts as a check on the “abuse of monopoly” originally envisioned by the Ayyangar Committee is essential to ensure that patent rights foster innovation without suffocating competition.
Citations
Expositor(s): Adv. Aparna Shukla, Adv. Archana Shukla
